Investment
Features
FeesSafety
Academy
More
Pluang+

Compare VanEck Gold Miners ETF (GDX) vs Nuwellis Inc (NUWE) Price & Performance

VanEck Gold Miners ETFTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

VanEck Gold Miners ETF vs Nuwellis Inc — how do they compare? VanEck Gold Miners ETF trades at $71.68, while Nuwellis Inc trades at $2.84 (market cap $1.10M). The key difference: VanEck Gold Miners ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

GDXNUWE
52-Week High
$115.84$558.26
52-Week Low
$51.15$2.80
Market Cap
$1.10M
Sector
Technology
Enterprise Value
-$709.83K

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Gold Miners ETF

The VanEck Gold Miners ETF (GDX) is trading at $71.97, down 3.89% over the past 24 hours, with a strong bearish technical signal from moving averages. The fund provides exposure to senior gold mining equities, which are currently trading at historically low valuations according to recent analysis, with forward P/E and EV/EBITDA multiples at five-year lows. Recent news highlights ongoing comparisons with lower-fee bullion ETFs and debates about the optimal vehicle for gold exposure.

The outlook presents a dichotomy: attractive valuation metrics and record free cash flow yields suggest potential upside if gold prices rally, while technical weakness and competition from more efficient gold ETFs pose significant risks. A re-rating to historical valuation norms could imply 20% upside, but the fund's performance remains heavily dependent on gold price movements and mining company operational execution.

Nuwellis Inc

Nuwellis (NUWE) trades at $3.22, up 15% in the last 24 hours, following a recent 35:1 reverse stock split executed on June 26, 2026. The medical technology company shows a mixed financial picture with a strong gross margin of 65.47% but significant net losses and negative profitability ratios. Recent news highlights expansion in pediatric care, new patent awards, and a $6 million public offering closed in June 2026 to fund operations. Technical indicators are predominantly bearish, with moving averages signaling strong selling pressure.

The outlook remains challenging due to persistent operating losses and negative cash flow, offset by strategic pediatric market expansion and new product innovation. Investment opportunity hinges on the company's ability to translate its high gross margin and recent capital raise into sustainable revenue growth and eventual profitability. Key risks include continued cash burn, execution of commercial strategy, and reliance on financing activities to fund operations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About VanEck Gold Miners ETF

The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.

Read more on GDX

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE